专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2023090881A1 혼합 생약 추출물을 포함하는 암의 예방 또는 치료용 약학적 조성물 및 건강기능식품 审中-公开
公开(公告)号：WO2023090881A1
公开(公告)日：2023-05-25
申请号：PCT/KR2022/018161
申请日：2022-11-17
申请人： 에이치앤오바이오시스(주)
发明人： 박종민
IPC分类号： A61K36/185 , A61K36/74 , A61K36/536 , A61K36/9066 , A61P35/00 , A23L33/105
摘要： 본 발명은 혼합 추출물을 포함하는 항암용 약학 조성물 또는 건강기능식품에 관한 것으로, 구체적으로 백화사설초, 하고초, 팔월찰, 봉출 및 울금의 혼합 추출물을 포함하는 것을 특징으로 한다. 본 발명에 따른 혼합 추출물은 다양한 암종에서 암 세포 증식 억제 및 전이 억제에 효과적이므로 항암용 약학조성물 또는 항암용 건강기능식품 등으로 유용하게 활용될 수 있다.

2. 发明申请

WO2022194912A1 COSMETIC COMPOSITION 审中-公开
公开(公告)号：WO2022194912A1
公开(公告)日：2022-09-22
申请号：PCT/EP2022/056783
申请日：2022-03-16
申请人： GIVAUDAN SA
发明人： SCANDOLERA, Amandine , REYNAUD, Romain
IPC分类号： A61P39/00 , A61K36/48 , A61K36/74 , A61Q17/04
摘要： The present invention provides a UV filter composition comprising coffee bean extract and Pongamia extract and a solar protection formulation comprising the UV filter composition.

3. 发明申请

WO2022180233A1 COMPOSITION NATURELLE RÉPULSIVE 审中-公开
公开(公告)号：WO2022180233A1
公开(公告)日：2022-09-01
申请号：PCT/EP2022/054841
申请日：2022-02-25
申请人： ANGELIDIS, Mathieu
发明人： ANGELIDIS, Mathieu
IPC分类号： A61K36/52 , A61K31/00 , A61K31/085 , A61K31/122 , A61K31/192 , A61K31/216 , A61K31/353 , A61K31/375 , A61K31/385 , A61K35/644 , A61K36/28 , A61K36/537 , A61K36/54 , A61K36/57 , A61K36/61 , A61K36/74 , A61K36/752 , A61P31/00 , A61P31/02 , A61P31/04 , A61P33/00 , A61K8/02 , A01M29/12 , A01N65/08 , A01N27/00 , A01N31/16 , A01N35/06 , A01N37/36 , A01N37/38 , A01N37/02 , A01N43/08 , A01N43/16 , A01N65/12 , A01N65/22 , A01N65/24 , A01N65/28 , A61K31/015 , A61K31/222 , A61K31/7024 , A61Q17/00 , A61Q17/02 , A61K8/31 , A61K8/33 , A61K8/34 , A61K8/35 , A61K8/36 , A61K8/37 , A61K8/49 , A61K8/67 , A61K8/9789
摘要： L'invention concerne une composition répulsive antiparasitaire et antimicrobienne, comprenant les ingrédients naturels suivants : au moins 0,2 % en poids, de germacrène, en particulier germacrène D; au moins 5 % en poids de tanins; au moins 1 % en poids d'acide(s) phénolique(s), distinct(s) de l'acide caféique, en particulier choisis parmi l'acide 3-caféoylquinique, l'acide 3-p-coumaroylquinique, l'acide 4-p-coumaroylique et leurs mélanges; au moins 55 % en poids d'eugénol; au moins 2 % en poids d'acétate d'eugénol; au moins 0,1 % en poids d'acide ascorbique; au moins 0,1 % en poids de trans-anéthole; au moins 0,1 % en poids de thuyone; et au moins 0,1 % en poids d'acide caféique, par rapport au poids total de matière sèche de la composition.

4. 发明申请

WO2022098192A1 한약복합추출물을 포함하는 악액질 예방 또는 치료용 조성물 审中-公开
公开(公告)号：WO2022098192A1
公开(公告)日：2022-05-12
申请号：PCT/KR2021/016150
申请日：2021-11-08
申请人： 경희대학교 산학협력단
发明人： 엄재영 , 안광석 , 양웅모 , 이석근 , 정윤우 , 박진봉
IPC分类号： A61K36/8905 , A61K36/74 , A61P43/00 , A61P21/00 , A61P37/00 , A61P35/00 , A23L33/105
摘要： 본 발명은 향부자(Cyperi Rhizoma) 및 천초(Zanthoxyli Pericarpium)의 복합추출물을 포함하는 악액질 예방, 개선 또는 치료용 조성물에 관한 것으로, 본 발명의 상기 복합추출물은 암에 의한 체중 감소 및 지방 손실을 억제하고, 암 세포사멸을 유도하는 효과를 나타내므로, 악액질 부작용 없이 항암 치료 및 악액질 개선이 동시에 가능한 암성 악액질 예방, 개선 또는 치료용 조성물로 유용할 수 있다.

5. 发明申请

WO2021191169A1 1,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR USE IN THE TREATMENT OF COVID-19 审中-公开
公开(公告)号：WO2021191169A1
公开(公告)日：2021-09-30
申请号：PCT/EP2021/057327
申请日：2021-03-22
申请人： ARTEMIFLOW GMBH
发明人： SEEBERGER, Peter , GILMORE, Kerry , MAUST, Adam, Jeffrey
IPC分类号： A61K31/357 , A61P31/14 , A61K36/282 , A61K36/74 , A61K31/19 , A61K31/216 , A61K31/343 , A61K31/352 , A61K31/366 , A61K31/573 , A61K45/06 , C07D323/06
摘要： The present invention relates to antiviral 1,2,4-trioxane compounds and compositions comprising the same that are effective inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication, and are thus useful to treat the coronavirus disease 2019 (COVID-19). The invention further provides pharmaceutical compositions containing such antiviral compounds and antiviral compositions, and methods of using these antiviral compounds, antiviral compositions and pharmaceutical compositions in the treatment and prevention of COVID-19.

6. 发明申请

WO2021133285A1 A HERBAL PERFORMANCE ENHANCEMENT MIX AND ITS PRODUCTION PROCESS 审中-公开
公开(公告)号：WO2021133285A1
公开(公告)日：2021-07-01
申请号：PCT/TR2020/050084
申请日：2020-02-07
申请人： MELİKOĞLU, Ahmet
发明人： OĞUL, Mahmut
IPC分类号： A61K35/644 , A61K36/31 , A61K36/258 , A61K36/906 , A61K36/54 , A61K36/23 , A61K36/16 , A61K36/67 , A61K36/42 , A61K36/60 , A61K36/53 , A61K36/61 , A61K36/29 , A61K36/74 , A61P15/08
摘要： The invention concerns with a mixture (1) of herbal and animal ingredients which enhances virility, increases sperm count and prevents cerebral arteriosclerosis in the user, as well as the production process (300) of this mixture (1) thereof.

7. 发明申请

WO2021085496A1 組成物、抗酸化剤、抗糖化剤、神経突起伸長促進剤及び認知機能改善剤审中-公开
公开(公告)号：WO2021085496A1
公开(公告)日：2021-05-06
申请号：PCT/JP2020/040502
申请日：2020-10-28
申请人：株式会社山田養蜂場本社
发明人：石川　朋美 , 奥村　暢章 , 西森　ちか , 藤岡　孝浩 , 八巻　礼訓 , 永井　寛子 , 浅間　孝志
IPC分类号： A61K35/644 , A23L21/20 , A23L33/10 , A23L33/105 , A61K31/12 , A61K31/121 , A61K31/685 , A61K36/16 , A61K36/23 , A61K36/74 , A61P3/10 , A61P17/18 , A61P25/00 , A61P25/28 , A61P39/06 , A61P43/00
摘要：プロポリス及びイチョウ葉抽出物を有効成分として含む、抗酸化剤、抗糖化剤、神経突起伸長促進剤、認知機能改善剤が開示される。

8. 发明申请

WO2021076849A1 NEW KRATOM COMPOSITIONS 审中-公开
公开(公告)号：WO2021076849A1
公开(公告)日：2021-04-22
申请号：PCT/US2020/055919
申请日：2020-10-16
申请人： CAAMTECH LLC
发明人： CHADEAYNE, Andrew R.
IPC分类号： A01N43/40 , A61K31/438 , A61K31/353 , A61K36/74
摘要： Disclosed are compositions containing two purified kratom compounds chosen from the following: 7-Hydroxymitragynine, Mitragynine, Paynantheine, Speciociliatine, Speciogynine, Ajmalicine, Ciliaphylline, Corynantheidine, Corynoxine A, Corynoxine B, Isomitraphylline, Isorhynchophylline, Mitraphylline, Rhynchophylline, Speciophylline, Speciofoline, Epicatechin, 7-Hydroxyspecioliatine, 9-Hydroxycorynantheidine, Corynoxeine, Isopteropodine, Isorhynchophylline Oxindole, Tetrahydroalstonine, Mitragynine Oxindole B, and Mitragynine Oxindole A or the salts of these kratom compounds. The disclosure also relates to formulations, including pharmaceutical formulations, of such a composition and an excipient. Pharmaceutical formulation further containing a therapeutically effective amount of a serotonergic drug, a purified psilocybin derivative, a purified cannabinoid, or a purified terpene a disclosed. Also disclosed are methods of regulating the activity of a neurotransmitter receptor and methods of treating a psychological disorder, a compulsive disorder, or a depressive disorder.

9. 发明申请

WO2019224300A3 TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION 审中-公开
公开(公告)号：WO2019224300A3
公开(公告)日：2019-11-28
申请号：PCT/EP2019/063318
申请日：2019-05-23
申请人： ETH ZURICH
发明人： QUITTERER, Ursula , ABDALLA, Said
IPC分类号： A61K31/421 , A61K31/4418 , A61K31/122 , A61K31/4439 , A61K31/454 , A61K36/062 , A61K36/07 , A61K36/09 , A61K36/74 , A61P25/00 , A61P25/28
摘要： The present invention is directed to a TOMM6 (Translocase of Outer Membrane 6kDa subunit homologue; Mitochondrial import receptor subunit TOM6 homolog)-interacting plant or fungal extract comprising an anthraquinone or anthraquinone derivative, a TOMM6-interacting anthraquinone or anthraquinone derivative, and TOMM6-interacting compounds for use in the treatment or prophylaxis of a nervous system disease, atherosclerosis, Hepatitis B infection and/or human papilloma virus (HPV) infection. Furthermore, the present invention relates to a corresponding method of therapeutic or prophylactic treatment of a nervous system disease or disorder, atherosclerosis, Hepatitis B infection and/or human papilloma virus (HPV) infection, as well as to a method for the identification of a TOMM6-interacting compound or composition. Also, the present invention provides a non-human transgenic animal expressing a transgenic, preferably human TOMM6 or a TOMM6 homolog.

10. 发明申请

WO2019200427A1 CAFFEINE COMPOSITIONS AND METHODS OF USE 审中-公开
公开(公告)号：WO2019200427A1
公开(公告)日：2019-10-24
申请号：PCT/AU2019/050336
申请日：2019-04-15
申请人： BARISTA MIST PTY LTD
发明人： CHIRILA, Traian Vasile , SMITH, Tai Mountford , SUZUKI, Shuko
IPC分类号： A61K36/74 , A61K31/522 , A61K9/08 , A61P25/30 , A61P43/00
摘要： A pharmaceutical composition formulated for intranasal administration comprising a natural caffeine extract, a pharmaceutically acceptable excipient, a pharmaceutically acceptable aqueous carrier; and, optionally, additional caffeine, or a pharmaceutically acceptable salt, solvate, derivative or metabolite thereof. Methods of preparation and methods of use are also described.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式